Literature DB >> 19148780

The effects of topiramate on caspase-3 expression in hippocampus of basolateral amygdala (BLA) electrical kindled epilepsy rat.

Xuqin Chen1, Guanshui Bao, Ying Hua, Yan Li, Zhedong Wang, Xueguang Zhang.   

Abstract

Caspase-3 expression was determined in the hippocampus of electrically kindled rats with and without topiramate treatment. Bipolar electrotrodes were implanted for chronic stimulation of the basolateral amygdala (BLA) to achieve a kindled state. Seizure and behavioral responses were observed, and video-electroencephalograms were recorded during and after kindling. After topiramate treatment (80 mg/kg, p.o.), the hippocampi were extracted and caspase-3 mRNA analyzed by semiquantitative RT-PCR. Caspase-3 immunoreactivity was determined with immunohistochemical staining. Topiramate treatment resulted in a significant decrease in the mean duration of seizures from 52 s in kindled rats to 13 s. The after-discharge duration was significantly decreased by 70% after topiramate treatment. Significant upregulations of both caspase-3 mRNA and caspase-3 immunoreactivity were observed in the kindled rats. These kindling-mediated increases in caspase-3 were prevented by topiramate treatment, and these levels were not different from those of sham-operated controls. In BLA-kindled rats, mRNA and immunoreactivity for caspase-3 were increased. Treatment with topiramate prevented the kindling-associated increases in caspase-3 as well as the increases in seizure duration and after-discharge duration. These data suggest that topiramate may have a neuroprotective role in addition to its action as an anticonvulsant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148780     DOI: 10.1007/s12031-008-9173-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate.

Authors:  X Zhang; A A Velumian; O T Jones; P L Carlen
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

2.  A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

Authors:  R D Elterman; T A Glauser; E Wyllie; R Reife; S C Wu; G Pledger
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

3.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

4.  Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent.

Authors:  Christian Frisch; Alexei P Kudin; Christian E Elger; Wolfram S Kunz; Christoph Helmstaedter
Journal:  Epilepsy Res       Date:  2006-11-02       Impact factor: 3.045

5.  Status epilepticus leads to the degradation of the endogenous inhibitor of caspase-activated DNase in rats.

Authors:  Alexei Kondratyev; Dawn Selby; Karen Gale
Journal:  Neurosci Lett       Date:  2002-02-22       Impact factor: 3.046

6.  Susceptibility of different cell layers of the anterior and posterior part of the piriform cortex to electrical stimulation and kindling: comparison with the basolateral amygdala and "area tempestas".

Authors:  W Löscher; U Ebert; U Wahnschaffe; C Rundfeldt
Journal:  Neuroscience       Date:  1995-05       Impact factor: 3.590

7.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.

Authors:  D W Nicholson; A Ali; N A Thornberry; J P Vaillancourt; C K Ding; M Gallant; Y Gareau; P R Griffin; M Labelle; Y A Lazebnik
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

8.  Survival and death-promoting events after transient spinal cord ischemia in rabbits: induction of Akt and caspase3 in motor neurons.

Authors:  Masahiro Sakurai; Tatsuya Nagata; Koji Abe; Takashi Horinouchi; Yasuto Itoyama; Koichi Tabayashi
Journal:  J Thorac Cardiovasc Surg       Date:  2003-02       Impact factor: 5.209

9.  Therapeutic doses of topiramate are not toxic to the developing rat brain.

Authors:  Carmen Glier; Mark Dzietko; Petra Bittigau; Bozena Jarosz; Elzbieta Korobowicz; Chrysanthy Ikonomidou
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

10.  Effect of topiramate following recurrent and prolonged seizures during early development.

Authors:  Byung Ho Cha; Diosely C Silveira; Xianzeng Liu; Yingchun Hu; Gregory L Holmes
Journal:  Epilepsy Res       Date:  2002-10       Impact factor: 3.045

View more
  1 in total

1.  Long-lasting recognition memory impairment and alterations in brain levels of cytokines and BDNF induced by maternal deprivation: effects of valproic acid and topiramate.

Authors:  Rose Mary Carvalho Pinheiro; Maria Noêmia Martins de Lima; Bernardo Chaves Dávila Portal; Stefano Boemler Busato; Lucio Falavigna; Rafael Dal Ponte Ferreira; André Contri Paz; Bianca Wollenhaupt de Aguiar; Flávio Kapczinski; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2014-09-03       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.